Improving Outcomes for Patients With Tenosynovial Giant Cell Tumor

Improving Outcomes for Patients With Tenosynovial Giant Cell Tumor is organized by Healio, Paradigm Medical Communications.

Release Date: October 22, 2025
Expiration Date: October 22, 2026

Description:
Tenosynovial giant cell tumor (TGCT) is a rare, often benign neoplasm that can mimic common joint disorders, leading to delayed diagnosis and treatment. This CME activity equips clinicians with the latest insights into TGCT, including its presentation, progression, and treatment options. With a focus on diffuse TGCT, which frequently recurs and impacts quality of life, participants will explore surgical challenges and medical treatment options. By enhancing diagnostic accuracy and familiarity with medical management, this activity empowers providers to deliver earlier, more effective care and support informed shared decision-making with patients.

Learning Objectives:
Upon completion of this activity, participants should be able to:

• Describe the hallmarks in the diagnosis of TGCT
• Review clinical trial data supporting the use of medical treatments for TGCT
• Develop evidence-based treatment plans for patients with TGCT